Clinical Trials Browser

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Triple Negative Breast Neoplasms

Adult Solid Tumor

Advanced Solid Tumor

Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Advanced Solid Tumours

Advanced Solid Tumor

Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Metastatic Solid Tumors

Advanced Solid Tumors

Solid Tumors

Parkinson Disease 4, Autosomal Dominant Lewy Body, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Advanced Solid Tumor

Solid Tumors

Solid Tumors

Solid Tumors

Mesothelioma, Malignant, Mesothelioma

Cholangiocarcinoma of the Gallbladder

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Advance Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Childhood Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific

Clinical Trials

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Study of RP-6306 With Gemcitabine in Advanced Solid Tumors

A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors

Imatinib Mesylate, Gemcitabine, and Capecitabine in Treating Patients With Advanced Solid Tumors

AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer

First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors

MK-1775-001

Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors

Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors

A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid Tumors

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

M6620 First in Human Study

A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors

A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma

Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

Irinotecan and Gemcitabine in Treating Patients With Refractory Advanced Solid Tumors

SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

LBH589 and Gemcitabine in the Treatment of Solid Tumors

Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer

Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors

Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors

Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors

Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors

Combination Chemotherapy In Treating Patients With Advanced Cancer

Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors

Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients

Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

Gemcitabine in Treating Children With Refractory Solid Tumors

Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors

GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Combination Chemotherapy in Treating Patients With Advanced Cancer

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors

Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid Malignancies

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer

BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors